Which of these healthcare stocks is more likely to prevail over the long term?
News & Analysis: Merck & Co.
Keytruda is now permitted for use in treating an aggressive form of bladder cancer.
Finally some good news from the American Cancer Society.
The star cancer immunotherapy missed an important endpoint during a study with small cell lung cancer.
This cancer-drug developer received a buyout offer from a big pharmaceutical company.
Which stock wins in a matchup between these two big drugmakers?
Which of these two pharmaceutical giants is poised to produce healthier returns?
Two big deals for cancer drug companies made news today. Merck plans to buy ArQule and Sanofi will pay up to buy Synthorx.
Merck's key growth driver may just be getting started.
The stock price is soaring. Are investors getting ahead of themselves by speculating on a potential acquisition?